Price target
49.000.000.00%
The 1 analyst offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
6733 EPS for the last quarter is −0.09 TWD despite the estimation of −0.09 TWD. In the next quarter EPS is expected to reach −0.10 TWD. Track more of BioGend Therapeutics Co., Ltd. financials and stay on top of what is up with the company.
In the next quarter BioGend Therapeutics Co., Ltd. revenue is expected to reach 60.00 M TWD. Check out BioGend Therapeutics Co., Ltd. revenue and earnings and make informed decisions.
According to analysts, 6733 price target is 49.00 TWD with a max estimate of 49.00 TWD and a min estimate of 49.00 TWD. Check if this forecast comes true in a year, meanwhile watch BioGend Therapeutics Co., Ltd. stock price chart and keep track of the current situation with 6733 news and stock market news.